Health
New Study Links GLP-1 to Lower Cognitive Decline in Diabetes
A widely used weight-loss drug known as GLP-1 receptor agonist may offer greater protection against dementia in people with type 2 diabetes than the commonly prescribed medication metformin, a new international study has found. Metformin continues to be the first treatment option for type 2 diabetes. However, GLP-